ORIGINAL RESEARCH
Published on 02 Jan 2025
Designing a Potent Multivalent epitope Vaccine candidate against Orientia tsutsugamushi via Reverse vaccinology technique -bioinformatics and
doi 10.3389/fimmu.2025.1513245
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Vaccines and Therapeutics Utilizing New Adjuvants and Potential Inhibitors to Target Emerging Infectious Diseases
Vaccines and Therapeutics Utilizing New Adjuvants and Potential Inhibitors to Target Emerging Infectious Diseases
1,186
Total downloads
5,114
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 26 Dec 2024
Designing a broad-spectrum multi-epitope subunit vaccine using an immunoinformatics and structural approach to strengthen the immune response against Leptospirosis
doi 10.3389/fimmu.2024.1503853
- 163 views
ORIGINAL RESEARCH
Published on 16 Dec 2024
Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: A multicentre, prospective, longitudinal cohort study
doi 10.3389/fimmu.2024.1446751
- 279 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
A gram-positive enhancer matrix particles vaccine displaying swine influenza virus haemagglutinin protects mice against lethal H1N1 viral challenge
doi 10.3389/fimmu.2024.1432989
- 148 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
Phage-resistance alters Lipid A reactogenicity: a new strategy for LPS-based conjugate vaccines against Salmonella Rissen
doi 10.3389/fimmu.2024.1450600
- 355 views
ORIGINAL RESEARCH
Published on 26 Nov 2024
Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae
doi 10.3389/fimmu.2024.1473193
- 532 views
REVIEW
Published on 01 Oct 2024
Future applications of host direct therapies for infectious disease treatment
doi 10.3389/fimmu.2024.1436557
- 782 views
ORIGINAL RESEARCH
Published on 29 Aug 2024
The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming
doi 10.3389/fimmu.2024.1439418
- 1,160 views
Published in
Frontiers in Immunology
- Vaccines and Molecular Therapeutics
Participating Journals
Frontiers in Public Health
Vaccines and Molecular TherapeuticsOffline
- 3.0 impact factor
- 4.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 5,114Topic views
- 3,329Article views
- 1,186Article downloads